Toni Kline
25Patents
10h-index
32Co-inventors
75Inventor score
Filing activity: Jul 6, 1990 → Nov 2, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7745394B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 149 | Active |
| US7964566B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 140 | Active |
| US7994135B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 124 | Active |
| US7964567B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 93 | Active |
| US5196404A | Inhibitors of thrombin | Emerging Cross-Sectional Technologies | 56 | Expired |
| US8703714B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 50 | Active |
| US8343928B2 | Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus | Emerging Cross-Sectional Technologies | 38 | Active |
| US5691311A | Methods for coating invasive devices with inhibitors of thrombin | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5433940A | Inhibitors of thrombin | Emerging Cross-Sectional Technologies | 26 | Expired |
| US8871720B2 | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus | Emerging Cross-Sectional Technologies | 25 | Active |
| US10808039B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 9 | Active |
| US10596270B2 | Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates | Chemistry; Metallurgy | 9 | Active |
| US8084615B2 | Antibacterial agents | Chemistry; Metallurgy | 9 | Active |
| US7989660B2 | Antibacterial agents | Chemistry; Metallurgy | 8 | Active |
| US8101640B2 | Antibacterial agents | Chemistry; Metallurgy | 8 | Active |
| US10414826B2 | Monomethylvaline compounds capable of conjugation to ligands | Emerging Cross-Sectional Technologies | 7 | Active |
| US8153843B2 | Antibacterial agents | Chemistry; Metallurgy | 4 | Active |
| US9522194B2 | Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus | Emerging Cross-Sectional Technologies | 1 | Active |
| US10844090B2 | Hemiasterlin derivatives for conjugation and therapy | Chemistry; Metallurgy | 1 | Active |
| US11866515B2 | Hemiasterlin derivatives for conjugation and therapy | Chemistry; Metallurgy | 0 | Active |
| US9034895B2 | Composition and methods for treating glioblastoma | Physics | 0 | Active |
| US8252940B2 | 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection | Chemistry; Metallurgy | 0 | Active |
| US10000555B2 | Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus | Emerging Cross-Sectional Technologies | 0 | Active |
| US12427201B2 | Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates | Chemistry; Metallurgy | 0 | Active |
| US12071477B2 | Anti-folate receptor alpha antibody conjugated with hemiasterlins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.